Picture of Anatara Lifesciences logo

ANR Anatara Lifesciences News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement Regarding Update On Phase II Garp-Ibs Trial

March 6 (Reuters) - Anatara Lifesciences Ltd ANR.AX:

SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING  UPDATE ON PHASE II GARP-IBS TRIAL

Further company coverage: ANR.AX

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Anatara Lifesciences

See all news